Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. QDEL
QDEL logo

QDEL Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy QuidelOrtho Corp (QDEL) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
13.670
1 Day change
4.11%
52 Week Range
35.580
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

QuidelOrtho Corp (QDEL) is not a strong buy at the moment for a beginner investor with a long-term focus. The stock has weak technical indicators, negative sentiment from analysts, and no significant positive catalysts. Insider buying is a positive sign, but it is outweighed by the broader risks and uncertainties.

Technical Analysis

The MACD is negative and expanding downward, indicating bearish momentum. RSI is neutral at 48.274, showing no clear trend. Moving averages are converging, which suggests indecision in price movement. The stock is trading near its support level of 13.118, with resistance at 15.112.

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
7

Positive Catalysts

  • Insiders are buying, with a significant 2578.44% increase in insider buying over the last month.

Neutral/Negative Catalysts

  • Analysts have downgraded the stock and significantly lowered price targets due to weak Q1 results, China policy headwinds, and uncertain deleveraging. No recent news or significant events to drive positive sentiment.

Financial Performance

Financial data for the latest quarter is unavailable, making it difficult to assess recent growth trends.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have a negative outlook on the stock. Price targets have been significantly reduced by UBS, JPMorgan, Jefferies, and Citi, citing weak performance and lingering risks.

Wall Street analysts forecast QDEL stock price to rise
4 Analyst Rating
Wall Street analysts forecast QDEL stock price to rise
1 Buy
3 Hold
0 Sell
Hold
Current: 13.130
sliders
Low
35
Averages
35
High
35
Current: 13.130
sliders
Low
35
Averages
35
High
35
UBS
Lu Li
Neutral
downgrade
$17 -> $12
AI Analysis
2026-05-07
Reason
UBS
Lu Li
Price Target
$17 -> $12
AI Analysis
2026-05-07
downgrade
Neutral
Reason
UBS analyst Lu Li lowered the firm's price target on QuidelOrtho to $12 from $17 and keeps a Neutral rating on the shares. The firm updated its model and tells investors in a research note that the overhang is likely to persist.
JPMorgan
Underweight
downgrade
$15 -> $11
2026-05-07
Reason
JPMorgan
Price Target
$15 -> $11
2026-05-07
downgrade
Underweight
Reason
JPMorgan lowered the firm's price target on QuidelOrtho to $11 from $15 and keeps an Underweight rating on the shares post the Q1 report. The firm cites weak respiratory results and China policy headwinds for the target cut.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for QDEL
Unlock Now

People Also Watch